Inhibikase Therapeutics, Inc. (IKT) Financials
IKT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 17.9 million | 2.9 million |
| 2023-06-30 | 22.3 million | 2.9 million |
| 2023-03-31 | 28.2 million | 2.8 million |
| 2022-12-31 | 24.9 million | 3.9 million |
IKT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -4.1 million | 129781 |
| 2023-06-30 | -4.6 million | 124845 |
| 2023-03-31 | -6.0 million | 123273 |
| 2022-12-31 | -3.4 million | 100363 |
IKT Net Income
No data available :(
IKT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 16.8 million | - | 270043 |
| 2023-06-30 | 20.9 million | - | 297937 |
| 2023-03-31 | 25.7 million | - | 325011 |
| 2022-12-31 | 23.1 million | - | 351287 |
IKT Shares Outstanding
IKT Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 3.2 million | 1.6 million | - |
| 2023-06-30 | 14238 | 4.5 million | 1.8 million | - |
| 2023-03-31 | - | 2.9 million | 1.9 million | - |
| 2022-12-31 | 200166 | 3.1 million | 1.3 million | - |
IKT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 79569 | 6568 |
| 2023-06-30 | 116410 | 159204 |
| 2023-03-31 | 64521 | 5043 |
| 2022-12-31 | 123440 | 5042 |
IKT
Price: $1.39
52 week price:
Earnings Per Share: -3.57 USD
P/E Ratio: -0.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 146895
Market Capitalization: 9.0 million